— Know what they know.
Not Investment Advice

News & Sentiment

Sentiment 42.3 2060 articles 1257 bullish 412 bearish Full Index →
15,000 Pounds of Guacamole: Tancítaro, Michoacán Reclaims "Avocado Capital" Titl

15,000 Pounds of Guacamole: Tancítaro, Michoacán Reclaims "Avocado Capital" Title with New Guinness World Record

The record-setting achievement underscores the industry's ability to deliver consistent, high-quality supply at scale as U.S. demand reaches historic highs. What to know: Certified by Guinness World Records, the 6.8-metric-ton (14,991-pound) bowl of guacamole shattered the previous 2022...
bullish 212710.KQ PRNewswire 9h ago
Elon Musk Agrees With Jensen Huang That Humans Shouldn't Be

Elon Musk Agrees With Jensen Huang That Humans Shouldn't Be Wrangling Spreadsheets, But Nvidia CEO Says People Who Use AI Will Have The Edge

Artificial intelligence will fundamentally reshape the global workforce, according to Nvidia Corp (NASDAQ:NVDA) CEO Jensen Huang, whose comments on...
Here are the 5 biggest takeaways from Google I/O

Here are the 5 biggest takeaways from Google I/O

Google AI chief Demis Hassabis discusses singularity at I/O 2026, showcasing AI innovations like Spark and Gemini amid coding challenges.
Webull Launches AI-Powered Stock Analysis Tool For Retail Tr

Webull Launches AI-Powered Stock Analysis Tool For Retail Traders

Webull Corp. (NASDAQ:BULL) on Tuesday launched Vega Analyst, a new AI-powered research tool that generates customized, real-time stock analysis for...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Tuesday's After-Market Sessi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding...
📰

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Cencora Inc. stock outperforms competitors on strong trading day  MarketWatch
8x8 Shares Soar After Q4 Report — Here's Why

8x8 Shares Soar After Q4 Report — Here's Why

8×8 Inc. (NASDAQ:EGHT) shares soared after the company posted its fourth-quarter results after Tuesday’s closing bell, beating analyst...
📰

Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch

Amgen Inc. stock outperforms competitors on strong trading day  MarketWatch
Keysight Stock Climbs On Record Q2 Earnings Beat: Details

Keysight Stock Climbs On Record Q2 Earnings Beat: Details

Keysight Technologies, Inc. (NYSE:KEYS) shares climbed after the company posted its second-quarter results after Tuesday’s closing bell,...
📰

Top Research Reports for Visa, IBM & CrowdStrike

Visa stays central to digital payments as cross-border activity and transaction growth fuel momentum despite margin pressure.
📰

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
📰

Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity

Phase IV head-to-head, double-blind trial comparing safety and efficacy met its primary and secondary endpoints The DIRECTION trial results show the...
📰

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
📰

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
📰

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
📰

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
📰

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
📰

These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets

ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.
Regeneron & Parabilis Sign Oncology Collaboration Worth Up t

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

REGN teams up with Parabilis in a potential $2.2B deal to develop Antibody-Helicon Conjugates targeting hard-to-treat cancers.
Regeneron & Parabilis Sign Oncology Collaboration Worth Up t

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

REGN teams up with Parabilis in a potential $2.2B deal to develop Antibody-Helicon Conjugates targeting hard-to-treat cancers.
Is CAH Becoming the Backbone of US Healthcare Infrastructure

Is CAH Becoming the Backbone of US Healthcare Infrastructure?

Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare...
Is CAH Becoming the Backbone of US Healthcare Infrastructure

Is CAH Becoming the Backbone of US Healthcare Infrastructure?

Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare...
Regeneron & Parabilis Sign Oncology Collaboration Worth Up t

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

REGN teams up with Parabilis in a potential $2.2B deal to develop Antibody-Helicon Conjugates targeting hard-to-treat cancers.
Is CAH Becoming the Backbone of US Healthcare Infrastructure

Is CAH Becoming the Backbone of US Healthcare Infrastructure?

Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare...
Regeneron & Parabilis Sign Oncology Collaboration Worth Up t

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

REGN teams up with Parabilis in a potential $2.2B deal to develop Antibody-Helicon Conjugates targeting hard-to-treat cancers.
📰

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain

Eli Lilly and Novo Nordisk are accelerating global obesity pill launches as rising GLP-1 demand puts weight-loss ETFs in focus.
📰

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain

Eli Lilly and Novo Nordisk are accelerating global obesity pill launches as rising GLP-1 demand puts weight-loss ETFs in focus.
📰

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain

Eli Lilly and Novo Nordisk are accelerating global obesity pill launches as rising GLP-1 demand puts weight-loss ETFs in focus.
📰

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain

Eli Lilly and Novo Nordisk are accelerating global obesity pill launches as rising GLP-1 demand puts weight-loss ETFs in focus.
📰

Samsung and Google detail AI smart glasses, putting pressure on Meta as Apple preps rival eyewear

Samsung and Google showed off their AI-powered smart glasses on Tuesday.
📰

Warby Parker Unveils First Intelligent Eyewear Design

NEW YORK, May 19, 2026--Warby Parker Inc. (NYSE: WRBY), a lifestyle brand focused on vision for all, today unveiled its first Intelligent Eyewear...
Trump's Stock Picks Perfectly Timed With New Medicare Rules:

Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report

President Donald Trump disclosed stock purchases worth as much as $680,000 in Eli Lilly & Co. (NYSE:LLY) earlier this year, with the trades...
Trump's Stock Picks Perfectly Timed With New Medicare Rules:

Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report

President Donald Trump disclosed stock purchases worth as much as $680,000 in Eli Lilly & Co. (NYSE:LLY) earlier this year, with the trades...
📰

Forget T-Bills. This Active ETF Is Paying More With Less Hassle.

If you’ve been parking cash in Treasury bills, you know the routine: log into TreasuryDirect, place an auction bid, wait for settlement, then...
What's Going On With Meiwu Technology Stock Today?

What's Going On With Meiwu Technology Stock Today?

Meiwu Technology Company Limited (NASDAQ:WNW) shares traded higher on Tuesday. Earlier this month, the company disclosed a new private financing deal...
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers InMed Pharmaceuticals (NASDAQ:INM) shares increased by 127.0% to $1.54 during Tuesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers InMed Pharmaceuticals (NASDAQ:INM) shares increased by 127.0% to $1.54 during Tuesday's regular session. The company's market cap...
« Prev 1 2 3 21 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms